GENLISA Quadrivalent Influenza Vaccine BV IgG Antilichaam (BV IgG) ELISA

The GENLISA Quadrivalent Influenza Vaccine BV IgG Antibody (BV IgG) ELISA includes features like: - Ready to use protocol with break-apart wells for ease of use - Standardisation and High Reproducibility - Lot to Lot Consistency - Accuracy and Precision Validated against seven points for a "GOLD RING" Standard Quality ELISA - the benchmark sign for Krishgen Quality. The GENLISA ELISA kits are used for assessing the specific biomarker in samples analytes which may be human serum, plasma, biological fluids and cell culture supernatant. The kit uses indirect sandwich assay with double antibodies - capture and detection to ensure a high degree of sensitivity and specificity in the estimation of the biomarker - antigen/antibody.

Assay Range: Qualitative | Sensitivity: 8 ng/ml Assay Range: | Sensitivity: Availability: 3 - 4 Weeks | Pack Size: 1 x 96 wells Availability: | Pack Size:

Qualitative

Sandwich ELISA, Double Antibody

Serum, Plasma, Cell Culture Supernatant, buffer based solutions (pH7.4) and other biological samples.

8 ng/ml

Shipped at Room Temperature or in gel pack to maintain temperature at 2-8 degrees Celsius

The kit (2-8 Degree Celsius) and its components are to be stored as indicated in the IFU (instructions for use) . To ensure quality of your results, if all the wells in the kit are not being used, store the unused wells in the foil pouch containing the desiccant pack, well sealed and store at the indicated temperature. Similary aliquot and store the reconstituted standard at -20 Degree Celsius for long term storage (maximum 6 months from reconstitution) and to avoid deterioration in the activity.

Vaccine Development :Influenza

This assay recognises Quadrivalent Influenza Vaccine BV IgG Antibody (BV IgG)

Quantitative Results Intepretation, 4PL (2nd order) or Cubic Spline Graph. Software (MS Excel) available, on request, to support interpretation of results.